VOICE Trial
A brain-computer interface clinical trial initiated by Neuralink, designed to read neural signals associated with language in the brain and help patients who have lost the ability to speak due to conditions such as ALS reconstruct speech or text output.
Timeline (last 90 days)
Neuralink announced the VOICE trial, aimed at helping people who have lost the ability to speak due to diseases such as ALS to speak again.
The goal of the VOICE trial is to directly convert a patient's communicative intent into outputtable speech or text by reading neural signals related to language from the brain.
All Facts (2)
The goal of the VOICE trial is to directly convert a patient's communicative intent into outputtable speech or text by reading neural signals related to language from the brain.
50%UnverifiedNeuralink announced the VOICE trial, aimed at helping people who have lost the ability to speak due to diseases such as ALS to speak again.
50%